Skip to main content
Livermore
Livermore
ZHEN

Abacus Planning Group, Inc.

SEC CIK
0001602730
Latest filing
Jul 20, 2026

PACB holding history

Pacific Biosciences of California, Inc. in every 13F filed by Abacus Planning Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PACB overviewAll 13F holders of PACBFull Q2 2026 holdings

Shares (Q2 2026)
51,238
Value
$86.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PACB by Abacus Planning Group, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202651,238$86.1K<0.1%00.0%UnchangedHolders
Q1 202651,238$67.6K<0.1%−48,762−48.8%ReducedHolders
Q4 2025100,000$187.0K<0.1%00.0%UnchangedHolders
Q3 2025100,000$128.0K<0.1%00.0%UnchangedHolders
Q2 2025100,000$124.0K<0.1%00.0%UnchangedHolders
Q1 2025100,000$118.0K<0.1%00.0%UnchangedHolders
Q4 2024100,000$183.0K<0.1%00.0%UnchangedHolders
Q3 2024100,000$170.0K<0.1%00.0%UnchangedHolders
Q2 2024100,000$137.0K<0.1%00.0%UnchangedHolders
Q1 2024100,000$375.0K0.1%00.0%UnchangedHolders
Q4 2023100,000$981.0K0.2%00.0%UnchangedHolders
Q3 2023100,000$835.0K0.2%00.0%UnchangedHolders
Q2 2023100,000$1.33M0.3%−20,000−16.7%ReducedHolders
Q1 2023120,000$1.39M0.4%00.0%UnchangedHolders
Q4 2022120,000$981.6K0.3%−20,000−14.3%ReducedHolders
Q3 2022140,000$813.0K0.2%00.0%UnchangedHolders
Q2 2022140,000$619.0K0.2%00.0%UnchangedHolders
Q1 2022140,000$1.27M0.3%−15,000−9.7%ReducedHolders
Q4 2021155,000$3.17M0.8%−25,000−13.9%ReducedHolders
Q3 2021180,000$4.60M1.5%00.0%UnchangedHolders
Q2 2021180,000$6.29M1.9%00.0%UnchangedHolders
Q1 2021180,000$6.00M1.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.